See more : Shikoku Chemicals Corporation (4099.T) Income Statement Analysis – Financial Results
Complete financial analysis of 908 Devices Inc. (MASS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 908 Devices Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- United Company RUSAL, International Public Joint-Stock Company (UNRIF) Income Statement Analysis – Financial Results
- Engine Gaming and Media, Inc. (GAME.V) Income Statement Analysis – Financial Results
- Coastal Contracts Bhd (5071.KL) Income Statement Analysis – Financial Results
- Scienjoy Holding Corporation (SJOYW) Income Statement Analysis – Financial Results
- Kappa Create Co., Ltd. (7421.T) Income Statement Analysis – Financial Results
908 Devices Inc. (MASS)
About 908 Devices Inc.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 50.23M | 46.85M | 42.21M | 26.89M | 17.97M | 22.05M |
| Cost of Revenue | 24.91M | 20.83M | 18.97M | 11.97M | 9.83M | 9.66M |
| Gross Profit | 25.32M | 26.02M | 23.23M | 14.92M | 8.14M | 12.39M |
| Gross Profit Ratio | 50.41% | 55.54% | 55.05% | 55.49% | 45.31% | 56.19% |
| Research & Development | 21.90M | 17.53M | 13.07M | 8.24M | 8.99M | 9.53M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 46.18M | 43.88M | 32.24M | 12.50M | 11.29M | 9.30M |
| Other Expenses | 0.00 | 1.82M | 386.00K | -6.03M | 301.00K | 50.00K |
| Operating Expenses | 68.08M | 61.41M | 45.30M | 20.74M | 20.29M | 18.83M |
| Cost & Expenses | 92.99M | 82.23M | 64.28M | 32.71M | 30.12M | 28.49M |
| Interest Income | 6.48M | 2.03M | 500.00K | 100.00K | 200.00K | 0.00 |
| Interest Expense | 201.00K | 129.00K | 486.00K | 976.00K | 1.53M | 1.15M |
| Depreciation & Amortization | 2.38M | 1.61M | 925.00K | 831.00K | 900.00K | 896.00K |
| EBITDA | -34.03M | -31.82M | -20.94M | -11.01M | -10.94M | -5.49M |
| EBITDA Ratio | -67.74% | -75.52% | -51.37% | -44.04% | -60.89% | -24.91% |
| Operating Income | -42.76M | -35.38M | -22.07M | -5.82M | -12.14M | -6.44M |
| Operating Income Ratio | -85.13% | -75.52% | -52.29% | -21.62% | -67.57% | -29.20% |
| Total Other Income/Expenses | 6.15M | 1.82M | -100.00K | -7.00M | -1.23M | -1.10M |
| Income Before Tax | -36.61M | -33.56M | -22.17M | -12.82M | -13.37M | -7.54M |
| Income Before Tax Ratio | -72.89% | -71.64% | -52.53% | -47.66% | -74.41% | -34.17% |
| Income Tax Expense | -211.00K | -1.82M | -53.00K | -5.88M | 1.83M | 50.00K |
| Net Income | -36.40M | -31.74M | -22.12M | -6.94M | -15.20M | -7.54M |
| Net Income Ratio | -72.47% | -67.75% | -52.40% | -25.79% | -84.60% | -34.17% |
| EPS | -1.13 | -1.01 | -0.79 | -0.25 | -0.58 | -0.40 |
| EPS Diluted | -1.13 | -1.01 | -0.79 | -0.25 | -0.58 | -0.40 |
| Weighted Avg Shares Out | 32.21M | 31.49M | 27.96M | 27.27M | 26.20M | 18.98M |
| Weighted Avg Shares Out (Dil) | 32.24M | 31.49M | 27.96M | 27.27M | 26.20M | 18.98M |
908 Devices Inc. (MASS) Q1 2024 Earnings Call Transcript
908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
908 Devices: Rare Early-Stage Bioprocess Investment Opportunity
3 Stocks Under $10 That Wall Street Sees More Than 100% Upside This Year
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
908 Devices Inc. (MASS) Q4 2023 Earnings Call Transcript
908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook
Source: https://incomestatements.info
Category: Stock Reports